| # | Title | Journal | Year | Citations |
|---|
| 1 | Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease | Gastroenterology | 2015 | 725 |
| 2 | Long‐term clearance of hepatitis C virus following interferon α‐2b or peginterferon α‐2b, alone or in combination with ribavirin | Journal of Viral Hepatitis | 2013 | 74 |
| 3 | Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010 | COPD: Journal of Chronic Obstructive Pulmonary Disease | 2017 | 61 |
| 4 | Serum Biomarkers Indicate Long-term Reduction in Liver Fibrosis in Patients With Sustained Virological Response to Treatment for HCV Infection | Clinical Gastroenterology and Hepatology | 2016 | 49 |
| 5 | Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes | Alimentary Pharmacology and Therapeutics | 2019 | 39 |
| 6 | Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study | American Journal of Gastroenterology | 2015 | 33 |
| 7 | Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma | Journal of Viral Hepatitis | 2016 | 30 |
| 8 | Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records | Clinical Epidemiology | 2017 | 28 |
| 9 | Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States | Journal of Viral Hepatitis | 2018 | 24 |
| 10 | Adjuvant ribavirin and longer direct‐acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure | Journal of Viral Hepatitis | 2019 | 21 |
| 11 | Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders | Hepatology | 2009 | 20 |
| 12 | Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection | Infectious Disease Clinics of North America | 2018 | 20 |
| 13 | Bioelectrical Impedance Analysis for the Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis C Infection | Digestive Diseases and Sciences | 2008 | 19 |
| 14 | Adefovir dipivoxil in chronic hepatitis B: history and current uses | Expert Opinion on Pharmacotherapy | 2012 | 19 |
| 15 | Sustained virological response does not improve long‐term glycaemic control in patients with type 2 diabetes and chronic hepatitis C | Liver International | 2019 | 17 |
| 16 | EUS-directed transgastric interventions in Roux-en-Y gastric bypass anatomy: a multicenter experience | Gastrointestinal Endoscopy | 2022 | 15 |
| 17 | Baricitinib and primary biliary cholangitis | Journal of Translational Autoimmunity | 2021 | 13 |
| 18 | Changing trends in complications of chronic hepatitis C | Liver International | 2018 | 12 |
| 19 | HLA haplotypes in primary sclerosing cholangitis patients of admixed and non‐European ancestry | Hla | 2017 | 9 |
| 20 | Management of Acute Hepatotoxicity Including Medical Agents and Liver Support Systems | Clinics in Liver Disease | 2017 | 9 |
| 21 | Long‐term progression of viral load and serum markers of fibrosis among treated and untreated patients with chronic hepatitis B | Journal of Gastroenterology and Hepatology (Australia) | 2017 | 9 |
| 22 | Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts | Advances in Therapy | 2021 | 7 |
| 23 | Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? | American Journal of Clinical Dermatology | 2021 | 6 |
| 24 | Trends in Diagnosed Chronic Hepatitis B in a US Health System Population, 2006–2015 | Open Forum Infectious Diseases | 2019 | 5 |
| 25 | Trends in Cirrhosis and Mortality by Age, Sex, Race, and Antiviral Treatment Status Among US Chronic Hepatitis B Patients (2006-2016) | Journal of Clinical Gastroenterology | 2021 | 4 |
| 26 | Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis C | American Journal of Gastroenterology | 2021 | 4 |
| 27 | Role of gastric per-oral endoscopic myotomy (G-POEM) in post-lung transplant patients: a multicenter experience | Endoscopy International Open | 2022 | 4 |
| 28 | <p>Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis</p> | Clinical Epidemiology | 2020 | 3 |
| 29 | Cold snare piecemeal endoscopic mucosal resection of a very large duodenal adenoma | Endoscopy | 2019 | 2 |
| 30 | Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma | Annals of Surgical Oncology | 2023 | 2 |
| 31 | Is there still a role for liver biopsy in managing hepatitis C virus infections? | Clinical Liver Disease | 2012 | 0 |
| 32 | Changing Trends in the United States Prevalence of Hepatitis B Core Antibody Provide Important Perspectives Into Future Screening and Vaccination Strategies | Journal of Infectious Diseases | 2021 | 0 |
| 33 | Autoimmune Autonomic Ganglionopathy Presenting as Constipation | Cureus | 2022 | 0 |
| 34 | Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States | Journal of Viral Hepatitis | 2022 | 0 |
| 35 | The Effect of the COVID-19 Pandemic in Intestinal Rehabilitation and Transplant Patients: Initial Results of the Intestinal Rehabilitation and Transplant Association’s International Survey | Transplantation | 2022 | 0 |
| 36 | Effects of the implementation of acuity circle policy on waitlist and post‐transplant outcomes of liver re‐transplantation | Clinical Transplantation | 0 | 0 |
| 37 | Splenic Artery Embolism in Liver Transplant Patients: A Single-Center Experience | Cureus | 2023 | 0 |
